Provided by Tiger Fintech (Singapore) Pte. Ltd.

HUA MEDICINE-B

3.870
+0.1102.93%
Volume:17.60M
Turnover:69.55M
Market Cap:4.09B
PE:-13.89
High:4.120
Open:3.750
Low:3.750
Close:3.760
52wk High:4.170
52wk Low:1.030
Shares:1.06B
HK Float Shares:1.06B
Volume Ratio:1.73
T/O Rate:1.67%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.279
ROE:209.75%
ROA:-9.41%
PB:3.53
PE(LYR):-13.89
PS:10.09

Loading ...

Stock Track | HUA MEDICINE-B Soars 5.88% Following Impressive Interim Results and First-Time Profitability

Stock Track
·
Yesterday

Stock Track | HUA MEDICINE-B Soars 5.88% on First-Half Profitability and Successful Commercialization

Stock Track
·
Yesterday

Hong Kong Stock Movement | HUA MEDICINE-B (02552) Surges Nearly 6% Again as Company Achieves First-Half Profitability with Remarkable Autonomous Commercialization Results

Stock News
·
Yesterday

Stock Track | HUA MEDICINE-B Soars 5.02% Following Strong H1 2025 Results and Promising Outlook

Stock Track
·
Aug 29

HUA MEDICINE-B (02552) Interim Report Review: First-Time Profitability During Reporting Period, Commercialization Transformation Entering Harvest Phase

Stock News
·
Aug 29

BRIEF-Hua Medicine Posts H1 Revenue Of RMB 217.4 Million

Reuters
·
Aug 28

Press Release: Hua Medicine Announces 2025 Interim Results

Dow Jones
·
Aug 28

HUA MEDICINE-B (02552) Achieves First-Time Profitability in First Half, Accelerates Overseas Expansion

Stock News
·
Aug 28

Hua Medicine H1 Revenue RMB 64.2 Million

THOMSON REUTERS
·
Aug 28

Corrected-Hua Medicine H1 Revenue RMB 217.4 Million (Corrects Amount)

THOMSON REUTERS
·
Aug 28

Hua Medicine (Shanghai) Ltd.'s (HKG:2552) market cap surged HK$354m last week, individual investors who have a lot riding on the company were rewarded

Simply Wall St.
·
Aug 16

Hua Medicine Forecasts Significant Profit Increase for 2025 Following Termination of Bayer Agreement and Successful Commercialization of HuaTangNing

Reuters
·
Jul 28

Hua Medicine - Expects RMB1,184.1 Mln Profit for Hy

THOMSON REUTERS
·
Jul 28

There's Reason For Concern Over Hua Medicine (Shanghai) Ltd.'s (HKG:2552) Massive 39% Price Jump

Simply Wall St.
·
Jul 18

Hua Medicine Announces Resignation of Non-Executive Director Dr. Fangxin Li Effective June 25, 2025

Reuters
·
Jun 25